Ipca Laboratories Ltd. has launched its Centre of Excellence (CoE) - a specialized training initiative aimed at providing hands-on industrial exposure to students aspiring to build a career in the pharmaceutical industry.
Experience in RM & PM analysis and document review with expertise in analytical techniques (HPLC, GC, UV, Dissolution), method validation, and regulatory compliance
The U.S. Food and Drug Administration has approved a new treatment combination of teclistamab‑cqyv with daratumumab and hyaluronidase‑fihj for adult patients with relapsed or refractory Multiple Myeloma. The approval offers a new therapeutic option for patients whose disease has returned or stopped responding after earlier treatments.
Graduation in life sciences (Molecular biology/ Biotechnology/ Microbiology/ Virology/ any other subjects related to health) plus Three years’ experience in relevant subject/ field OR Postgraduate in relevant subject/ field (Molecular biology / Biotechnology/ Microbiology/ Virology/ any other subjects related to health)
PhD in chemistry / material sciences / Pharmaceutical Sciences OR M. Pharm having 03 years of research, design and development experience with at least three research papers in Science Citation Indexed journal.